Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194350 · ClinicalTrials.gov registry record
Factor V Leiden Mutation and Implantation Failure
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 399
- Enrollment target
NCT00194350: Completed study, sponsored by University of Pennsylvania.
NCT00194350 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 399 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194350 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether inherited thrombophilias (tendency toward blood clotting) increase the risk of failure of the embryo to implant in IVF. The specific condition to be studied is the presence or absence of the Leiden mutation of the Factor V gene.
Interventions
- PROCEDURE Test for Factor V Leiden gene mutation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2001-09 |
| Est. Completion | 2005-08 |
What the finished NCT00194350 record still lists
NCT00194350 is an observational study that tracks outcomes without assigning an intervention. The registered 399 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Test for Factor V Leiden gene mutation is the first listed.
NCT00194350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00194350 about?
NCT00194350 is a clinical study titled "Factor V Leiden Mutation and Implantation Failure". The purpose of this study is to determine whether inherited thrombophilias (tendency toward blood clotting) increase the risk of failure of the embryo to implant in IVF. The specific condition to be studied is the presence or absence of the Leiden mutation of the Factor V gene.
What is the current status of trial NCT00194350?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2001-09. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00194350?
The interventions under investigation include: Test for Factor V Leiden gene mutation (PROCEDURE).
Who is sponsoring clinical trial NCT00194350?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia